Role of galectins in inflammatory and immunomodulatory processes

Biochimica et Biophysica Acta - General Subjects

Volumn 1572, Issue 2-3, 2002, Pages 274-284

  Rabinovich, Gabriel A ^a   Rubinstein, Natalia ^a   Toscano, Marta A ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

Apoptosis; Autoimmunity; Galectin; Immunomodulation; Inflammation

Indexed keywords

BETA GALACTOSIDE; CHEMOATTRACTANT; ECALECTIN; GALECTIN 1; GALECTIN 12; GALECTIN 3; GALECTIN 7; GALECTIN 8; LECTIN; LIGAND; PROTEIN; UNCLASSIFIED DRUG;

ALLERGY; AUTOIMMUNITY; BACTERIAL INFECTION; CELL DEATH; CELL INTERACTION; CELL PROLIFERATION; CELL SURVIVAL; DISEASE SEVERITY; EXTRACELLULAR MATRIX; HOMEOSTASIS; HUMAN; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOPATHOLOGY; INFLAMMATION; MOLECULAR DYNAMICS; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE; THYMOCYTE; THYMUS; TRYPANOSOMA CRUZI;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; APOPTOSIS; AUTOIMMUNE DISEASES; CELL DIVISION; GALECTINS; HEMAGGLUTININS; HUMANS; HYPERSENSITIVITY; IMMUNITY; INFLAMMATION; LYMPH NODES; SPLEEN; T-LYMPHOCYTES; THYMUS GLAND;

ANIMALIA;

EID: 0037136408     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(02)00314-8     Document Type: Review

References (105)

1. Van Parijs L., Abbas A.K. Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science. 280:1998;243-253.
2. Cooper D.N.W., Barondes S.H. God must love galectins; he made so many of them. Glycobiology. 9:1999;919-984.
3. Liu F.-T. Galectins: a new family of regulators of inflammation. Clin. Immunol. 97:2000;79-88.
4. Rabinovich G.A. Galectins: an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy. Cell Death Differ. 6:1999;711-721.
5. Rabinovich G.A., Rubinstein N., Fainboim L. Unlocking the secrets of galectins: a challenge at the frontiers of glyco-immunology. J. Leukocyte Biol. 71:2002;791-797.
6. Gabius H.-J., André S., Kaltner H., Siebert H.-C. The sugar code: functional lectinomics. Biochim. Biophys. Acta. 2002;. in press.
7. Kilpatrick D.C. Animal lectins: an historical introduction and overview. Biochim. Biophys. Acta. 1572:2002;187-197.
8. Loris R. Principles of structures of animal and plant lectins. Biochim. Biophys. Acta. 1572:2002;198-208.
9. Cooper D.N.W. Galectinomics: a lesson in complexity. Biochim. Biophys. Acta. 1572:2002;209-231.
10. Hirabayashi J., Hashidate T., Nishi N., Nakamura T., Hirashima M., Urashima T., Oka T., Futai M., Muller W.E.G., Yagi F., Kasai K. How galectins have evolved oligosaccharide specificity? Biochim. Biophys. Acta. 1572:2002;232-254.
11. Mehul B., Hughes R.C. Plasma membrane targetting, vesicular budding and release of galectin-3 from the cytoplasm of mammalian cells during secretion. J. Cell Sci. 110:1997;1169-1178.
12. Osborne B.A. Apoptosis and the maintenance of the homeostasis in the immune system. Curr. Opin. Immunol. 8:1996;245-254.
13. Perillo N.L., Uittenbogaart C.H., Nguyen J.T., Baum L.G. Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes. J. Exp. Med. 97:1997;1851-1858.
14. Goldstone S.D., Lavin M.F. Isolation of a cDNA clone, encoding a human β-galactoside-binding protein overexpressed during glucocorticoid-induced cell death. Biochem. Biophys. Res. Commun. 178:1991;746-750.
15. Baum L.G., Pang M., Perillo N.L., Wu T., Delegaene A., Uittenbogaart C.H., Fukuda M., Seilhamer J.J. Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells. J. Exp. Med. 181:1995;877-887.
16. - phenotype in developing thymocytes. J. Biol. Chem. 268:1993;3801-3804.
17. Brewer C.F., Dam T.K. Binding and cross-linking properties of galectins. Biochim. Biophys. Acta. 1572:2002;255-262.
18. Ramström O., Lehn J.-M. Combinatorial libraries: tools to define high-affinity lectin ligands. Biochim. Biophys. Acta. 1572:2002;178-186.
19. Walzel H., Blach M., Hirabayashi J., Kasai K.I., Brock J. Involvement of CD2 and CD3 in galectin-1-induced signalling in human Jurkat T-cells. Glycobiology. 10:2000;131-140.
20. Fouillit M., Joubert-Caron R., Poirier F., Bourin P., Monostori E., Levi-Strauss M., Raphael M., Bladier D., Caron M. Regulation of CD45-signalling by galectin-1 in Burkitt lymphoma B cells. Glycobiology. 10:2000;413-419.
21. Perillo N.L., Pace K.E., Seilhamer J.J., Baum L.G. Apoptosis of T cells mediated by galectin-1. Nature. 378:1995;736-739.
22. Pace K.E., Lee C., Stewart P.L., Baum L.G. Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. J. Immunol. 163:1999;3801-3811.
23. Pace K.E., Hahn H.P., Pang M., Nguyen J.T., Baum L.G. CD7, delivers a pro-apoptotic signal during galectin-1-induced T cell death. J. Immunol. 165:2000;2331-2334.
24. Wallace V.A., Penninger J.M., Kishihara K., Timms E., Shahinian A., Pircher H., Kundig T.M., Ohashi P.S., Mak T.W. Alterations in the level of CD45 surface expression affect the outcome of thymic selection. J. Immunol. 158:1997;3207-3214.
25. Vespa G.N., Lewis L.A., Kozak K.R., Moran M., Nguyen J.T., Baum L.G., Miceli M.C. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibit IL-2 production and proliferation. J. Immunol. 162:1999;799-806.
26. Wada J., Ota K., Kumar A., Wallner E.I., Kanwar Y.S. Developmental regulated expression and apoptotic potential of galectin-9, a β-galactoside-binding lectin. J. Clin. Invest. 99:1997;2452-2461.
27. Kruisbeek A.M., Amsen D. Mechanisms underlying T-cell tolerance. Curr. Opin. Immunol. 8:1996;233-244.
28. Blaser C., Kaufmann M., Muller C., Zimmermann C., Wells V., Malluci L., Pircher H. β-Galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. Eur. J. Immunol. 28:1998;2311-2319.
29. Allione A., Wells V., Forni G., Mallucci L., Novelli F. β-Galactoside-binding protein (β-GBP) alters the cell cycle, up-regulates expression of the α- and β-chains of the IFN-γ receptor, and triggers IFN-γ-mediated apoptosis of activated human T lymphocytes. J. Immunol. 161:1998;2114-2119.
30. Rabinovich G.A., Modesti N.M., Castagna L.F., Landa C.A., Riera C.M., Sotomayor C.E. Specific inhibition of lymphocyte proliferation and induction of apoptosis by CLL-I, a β-galactoside-binding lectin. J. Biochem. 122:1997;365-373.
31. Schneller M., Andre S., Cihak J., Kaltner H., Rademaker G., Haverkamp J., Thomas-Oates J.E., Losch U., Gabius H. Differential binding of two chicken β-galactoside-specific lectins to homologous lymphocyte subpopulations and evidence for inhibitory activity of the dimeric lectin on stimulated T cells. Cell. Immunol. 166:1995;35-43.
32. Novelli F., Allione A., Wells V., Forni G., Mallucci L. Negative cell cycle control of human T cells by beta-galactoside-binding protein (beta GBP): induction of programmed cell death in leukaemia cells. J. Cell. Physiol. 178:1999;102-108.
33. Wells V., Mallucci L. Identification of an autocrine negative growth factor: mouse β-galactoside-binding protein is a cytostatic factor and cell growth regulator. Cell. 64:1991;91-97.
34. Adams L., Scott G.K., Weinberg C.S. Biphasic modulation of cell growth by recombinant human galectin-1. Biochim. Biophys. Acta. 1312:1996;137-144.
35. Rabinovich G.A., Daly G., Dreja H., Tailor H., Riera C.M., Hirabayashi J., Chernajovsky Y. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J. Exp. Med. 190:1999;385-397.
36. Zimmermann C., Rawiel M., Blaser C., Kaufmann M., Pircher H. Homeostatic regulation of CD8+ T cells after antigen challenge in the absence of Fas (CD95). Eur. J. Immunol. 26:1996;2903-2910.
37. Rabinovich G.A., Iglesias M.M., Modesti N.M., Castagna L.F., Todel C.W., Riera C.M., Sotomayor C.E. Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T-cells: biochemical and functional characterization. J. Immunol. 160:1998;4831-4840.
38. Rabinovich G.A., Alonso C.R., Sotomayor C.E., Durand S., Bocco J.L., Riera C.M. Molecular mechanisms implicated in galectin-1-induced apoptosis: activation of the AP-1 transcription factor and downregulation of Bcl-2. Cell Death Differ. 7:2000;747-753.
39. Nguyen J.T., Evans D.P., Galvan M., Pace K.E., Leitenberg D., Bui T.N., Baum L.G. CD45 modulates galectin-1-induced T cell death: regulation by expression of core 2-O-glycans. J. Immunol. 167:2001;5697-5707.
40. Kopitz J., von Reitzenstein C., Burchert M., Cantz M., Gabius H.J. Galectin-1 is a major receptor for ganglioside GM1, a product of the growth-controlling activity of a cell surface ganglioside sialidase, on human neuroblastoma cells in culture. J. Biol. Chem. 273:1998;11205-11211.
41. Gabius H.J. Probing the cons and pros of lectin-induced immunomodulation: cases studies for the mistletoe lectin and galectin-1. Biochimie. 83:2001;659-666.
42. Rabinovich G.A., Castagna L.F., Landa C.A., Riera C.M., Sotomayor C.E. Regulated expression of a 16 kDa galectin-like protein in activated rat macrophages. J. Leukocyte Biol. 59:1996;363-370.
43. Zúñiga E.I., Rabinovich G.A., Iglesias M.M., Gruppi A. Regulated expression of galectin-1 during B cell activation and implications for T-cell apoptosis. J. Leukocyte Biol. 70:2001;73-79.
44. Rabinovich G.A., Ramhorst R.E., Rubinstein N., Corigliano A., Daroqui M.C., Kier-Joffé E.B., Fainboim L. Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and non-apoptotic mechanisms. Cell Death Differ. 9:2002;661-670.
45. Chung C.D., Patel V.P., Moran M., Lewis L.A., Miceli M.C. Galectin-1 induces partial TCR ζ-chain phosphorylation and antagonizes processive TCR signal transduction. J. Immunol. 165:2000;3722-3729.
46. Maldonado C.A., Castagna L.F., Rabinovich G.A., Landa C.A. Immunocytochemical study of the distribution of a 16-kDa galectin in the chicken retina. Invest. Ophthalmol. Visual Sci. 40:1999;2971-2977.
47. Iglesias M.M., Rabinovich G.A., Ivanovic V., Sotomayor C.E., Todel C.W. Galectin-1 from ovine placenta: amino-acid sequence, physicochemical properties and implications in T-cell death. Eur. J. Biochem. 252:1998;400-407.
48. Wollina U., Schreiber G., Gornig M., Feldrappe S., Burchert M., Gabius H.J. Sertoli cell expression of galectin-1 and -3 and accessible binding sites in normal human testis and Sertoli cell only-syndrome. Histol. Histopathol. 14:1999;779-784.
49. Visegrady B., Than N.G., Killar F., Sumegi B., Than G.N., Bohn H. Homology modelling and molecular dynamics studies of human placental tissue protein 13 (galectin-13). Protein Eng. 14:2001;875-880.
50. Ogden A.T., Nunez I., Ko K., Wu S., Hines C.S., Wang A.F., Hegde R.S., Lang R.A. GRIFIN, a novel lens-specific protein related to the galectin family. J. Biol. Chem. 273:1998;28889-28896.
51. Yang R.Y., Hsu D.K., Liu F.-T. Expression of galectin-3 modulates T cell growth and apoptosis. Proc. Natl. Acad. Sci. U. S. A. 93:1996;6737-6742.
52. Liu F.-T., Patterson R.J., Wang J.L. Intracellular functions of galectins. Biochim. Biophys. Acta. 1572:2002;263-273.
53. Joo H.G., Goedegebuure P.S., Sadanaga N., Nagoshi M., von Bernstorff W., Eberlein T.J. Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes. J. Leukocyte Biol. 69:2001;555-564.
54. Moon B.K., Lee Y.L., Battle P., Jessup J.M., Raz A., Kim H.R. Galectin-3 protects human breast carcinoma cells against nitric oxide-induced apoptosis: implication of galectin-3 function during metastasis. Am. J. Pathol. 159:2001;1055-1060.
55. Kim H.R., Lin H.M., Birilan H., Raz A. Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. Cancer Res. 59:1999;4148-4154.
56. Matarrese P., Tinari N., Semeraro M.L., Natoli C., Iacobelli S., Malorni W. Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis. FEBS Lett. 473:2000;311-315.
57. Yoshii T., Fukumori T., Honjo Y., Inohara H., Kim H.R., Raz A. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J. Biol. Chem. 277:2002;6852-6857.
58. Inohara H., Akahani S., Raz A. Galectin-3 stimulates cell proliferation. Exp. Cell. Res. 245:1998;294-302.
59. Bernerd F., Sarasin A., Magnaldo T. Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinotyes. Proc. Natl. Acad. Sci. U. S. A. 96:1999;11329-11334.
60. Hadari Y.R., Arbel-Goren R., Levy Y., Amsterdam A., Alon R., Zakut R., Zick Y. Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis. J. Cell Sci. 113:2000;2385-2397.
61. Yang R.Y., Hsu D.K., Yu L., Ni J., Liu F.-T. Cell cycle regulation by galectin-12, a new member of the galectin superfamily. J. Biol. Chem. 276:2001;20252-20260.
62. Cooper D.N.W. Galectin-1: secretion and modulation of cell interactions with laminin. Trends Glycosci. Glycotechnol. 9:1997;57-67.
63. Rabinovich G.A., Ariel A., Hershkoviz R., Hirabayashi J., Kasai K.I., Lider O. Specific inhibition of T-cell adhesion to extracellular matrix and pro-inflammatory cytokine secretion by human recombinant galectin-1. Immunology. 97:1999;100-106.
64. van den Brüle F.A., Buicu C., Baldet M., Sobel M.E., Cooper D.N.W., Marschal P., Castronovo V. Galectin-1 modulates human melanoma cell adhesion to laminin. Biochem. Biophys. Res. Commun. 209:1995;760-767.
65. Kuwabara I., Liu F.-T. Galectin-3 promotes adhesion of human neutrophils to laminin. J. Immunol. 156:1996;3939-3944.
66. Swarte V.V., Mebius R.E., Joziasse D.H., van den Eijnden D.H., Kraal G. Lymphocyte triggering via L-selectin leads to enhanced galectin-3-mediated binding to dendritic cells. Eur. J. Immunol. 28:1998;2846-2871.
67. André S., Kojima S., Yamazaki N., Fink C., Kaltner H., Kayser K., Gabius H. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity. J. Cancer Res. Clin. Oncol. 125:1999;461-474.
68. Danguy A., Camby I., Kiss R. Galectins and cancer. Biochim. Biophys. Acta. 1572:2002;285-293.
69. Rossiter H., Alon R., Kupper T.S. Selectins, T-cell rolling and inflammation. Mol. Med. Today. 3:1997;214-222.
70. Angata T., Brinkman-van der Linden E.C.M. I-type lectins. Biochim. Biophys. Acta. 1572:2002;294-316.
71. Matsumoto R., Matsumoto H., Seki M., Hata M., Asano Y., Kanegasaki S., Stevens R.L., Hirashima M. Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J. Biol. Chem. 273:1998;16976-16984.
72. Sano H., Hsu D.K., Yu L., Apgar J.R., Kuwabara I., Yamanaka T., Hirashima M., Liu F.-T. Human galectin-3 is a novel chemoattract for monocytes and macrophages. J. Immunol. 165:2000;2156-2164.
73. Rabinovich G.A., Sotomayor C.E., Riera C.M., Bianco I., Correa S.G. Evidence of a role for galectin-1 in acute inflammation. Eur. J. Immunol. 30:2000;1331-1339.
74. Zuberi R.I., Frigeri L.G., Liu F.-T. Activation of rat basophilic leukemia cells by εBP, an IgE-binding endogenous lectin. Cell. Immunol. 156:1994;1-12.
75. Yamaoka A., Kuwabara I., Frigeri L.G., Liu F.-T. A human lectin, galectin-3 (epsilon-BP/ Mac-2) stimulates superoxide production by neutrophils. J. Immunol. 154:1995;3479-3487.
76. Karlsson A., Follin P., Leffler H., Dahigren C. Galectin-3 activates the NADPH oxidase in exudated but not peripheral blood neutrophils. Blood. 91:1998;3430-3438.
77. Jeng K.C.G., Frigeri L.G., Liu F.-T. An endogenous lectin, galectin-3 (εBP/Mac-2) potentiates IL-1 production by human monocytes. Immunol. Lett. 42:1994;113-116.
78. Colnot C., Ripoche M.A., Milon G., Montagutelli X., Crocker P.R., Poirier F. Maintenance of granulocyte numbers during acute peritonitis is defective in galectin-3-null mutant mice. Immunology. 94:1998;290-296.
79. Hsu D.K., Yang R.-Y., Yu L., Pan Z., Salomon D.R., Fung-Leung W.-P., Liu F.-T. Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. Am. J. Pathol. 156:2000;1073-1083.
80. Sato S., Hughes R.C. Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages. J. Biol. Chem. 269:1994;4424-4430.
81. Gillenwater A., Xu X.C., Estrov Y., Sacks P.G., Lotan D., Lotan R. Modulation of galectin-1 content in human head and neck squamous carcinoma cells by sodium butirate. Int. J. Cancer. 75:1998;217-224.
82. Yoshida H., Imaizumi T., Kumagai M., Kimura K., Satoh C., Hanada N., Fujimoti K., Nishi N., Tanji K., Matsumiya T., Mori F., Cui X.F., Tamo W., Shibata T., Takanashi S., Okumura K., Nakamura T., Wakabayash K., Hirashima M., Sato Y., Satoh K. Interleukin-1 beta stimulates galectin-9 expression in human astrocytes. NeuroReport. 12:2001;3755-3758.
83. Rabinovich G.A., Rubinstein N., Matar P., Rozados V., Gervasoni S., Scharovsky O.G. The anti-metastatic effect of a single low-dose cyclophosphamide involves modulation of galectin-1 and Bcl-2 expression. Cancer Immunol. Immunother. 50:2002;587-603.
84. Lu J., Teh C., Kishore U., Reid K.B.M. Collectins and ficolins: sugar pattern recognition molecules of the mammalian innate immune system. Biochim. Biophys. Acta. 1572:2002;387-400.
85. Kilpatrick D.C. Mannan-binding lectins: clinical significance and applications. Biochim. Biophys. Acta. 1572:2002;401-413.
86. Kawabata S. Tachylectins: a family of defense molecules in invertebrate innate immunity. Biochim. Biophys. Acta. 1572:2002;414-421.
87. Offner H., Celnik B., Bringman T., Casentini-Borocz D., Nedwin G.E., Vanderbark A. Recombinant human β-galactoside-binding lectin suppresses clinical and histological signs of experimental autoimmune encephalomyelitis. J. Neuroimmunol. 28:1990;177-184.
88. Cebo C., Vergoten G., Zanetta J.-P. Lectin activities of cytokines: functions and putative carbohydrate recognition domains. Biochim. Biophys. Acta. 1572:2002;422-434.
89. Santucci L., Fiorucci S., Cammilleri F., Servillo G., Federici B., Morelli A. Galectin-1 exerts immunomodulatory and protective effects on concanavalin A-induced hepatitis in mice. Hepatology. 31:2000;399-406.
90. Levy G., Tarrab-Hazdai R., Teichberg V.I. Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits. Eur. J. Immunol. 13:1983;500-507.
91. Tuchiyama Y., Wada J., Zhang H., Morita Y., Hiragushi K., Hida K., Shikata K., Yamamura M., Kanwar Y.S., Makino H. Efficacy of galectins in the amelioration of nephrotoxic serum nephritis in Wistar Kyoto rats. Kidney Int. 58:1999;1941-1952.
92. Demetriou N., Granovsky M., Quaggin S., Dennis J.W. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature. 409:2001;733-739.
93. Harjacek M., Díaz-Cano S., Miguel M., Wolfe H., Maldonado C., Rabinovich G.A. Expression of galectins-1 and -3 correlates with defective mononuclear cell apoptosis in patients with juvenile rheumatoid arthritis. J. Rheumatol. 28:2001;1914-1922.
94. Lutomski D., Joubert-Caron R., Lefebure C., Salama J., Belin C., Bladier D., Caron M. Anti-galectin-1 autoantibodies in serum of patients with neurological diseases. Clin. Chim. Acta. 262:1997;131-138.
95. Giordanengo L., Gea S., Barbieri G., Rabinovich G.A. Anti-galectin-1 autoantibodies in human Trypanosoma cruzi infection: differential expression of this β-galactoside-binding protein in cardiac Chagas' disease. Clin. Exp. Immunol. 124:2001;266-273.
96. Jensen-Jarolim E., Neumann C., Oberhuber G., Gscheidlinger R., Neuchrist C., Reinisch W., Zuberi R.I., Penner E., Liu F.-T., Boltz-Nitulescu G. Anti-galectin-3 IgG autoantibodies in patients with Crohn's disease characterized by means of phage display peptide libraries. J. Clin. Immunol. 21:2001;348-356.
97. Cortegano I., del Pozo V., Cardaba B., de Andres B., Gallardo S., delAmo A., Arrieta I., Jurado A., Palomino P., Liu F.-T., Lahoz C. Galectin-3 down-regulates IL-5 gene expression on different cell types. J. Immunol. 161:1998;385-389.
98. Cortegano I., del Pozo V., Cardaba B., Arrieta I., Gallardo S., Rojo M., Aceituno E., Takai T., Verbeek S., Palomino P., Liu F.-T., Lahoz C. Interaction between galectin-3 and FCγRII induces down-regulation of IL-5 gene: implication of the promoter sequence IL-5REIII. Glycobiology. 10:2000;237-242.
99. Ackerman S.J., Corrette S.E., Rosenberg H.F., Bennet J.C., Mastrianni D.M., Nicholson-Weller A., Weller P.F., Chin D.T., Tenen D.G. Molecular cloning and characterization of human eosinophil Charcot-Leyden cristal protein (lysophospholipase). J. Immunol. 150:1993;456-468.
100. Dunphy J.L., Barcham G.J., Bischof R.J., Young A.R., Nash A., Meeusen E.N. Isolation and characterization of a novel eosinophil-specific galectin released into the lungs in response to allergen challenge. J. Biol. Chem. 277:2002;14916-14924.
101. Zuñiga E., Gruppi A., Hirabayashi J., Kasai K.I., Rabinovich G.A. Regulated expression and effect of galectin-1 on Trypanosoma cruzi-infected macrophages: modulation of microbicidal activity and survival. Infect. Immun. 69:2001;6804-6812.
102. Sato S., Ouellet N., Pelletier I., Simard M., Rancourt A., Bergeron M.G. Role of galectin-3 as an adhesion molecule for neutrophil extravasation during Streptococcal pneumonia. J. Immunol. 168:2002;1813-1822.
103. Mey A., Leffler H., Hmama Z., Normier G., Revillard J.P. The animal lectin galectin-3 interacts with bacterial lipopolysaccharides via two independent sites. J. Immunol. 156:1996;1572-1577.
104. Hsu D.K., Hammes S.R., Kuwabara I., Greene W.C., Liu F.-T. Human T lymphotropic virus-I infection of human T lymphocytes induces expression of the beta-galactoside binding lectin, galectin-3. Am. J. Pathol. 148:1996;1661-1670.
105. Fogel S., Guittaut M., Legrand A., Monsigny M., Hebert E. The Tat protein of HIV-1 induces galectin-3 expression. Glycobiology. 9:1999;383-387.